The involvement of myosin regulatory light chain diphosphorylation in sustained vasoconstriction under pathophysiological conditions

Journal of Smooth Muscle Research

Volumn 50, Issue 1, 2014, Pages 18-28

  Takeya, Kosuke ^a,b   Wang, Xuemei ^c   Sutherland, Cindy ^b   Kathol, Iris ^b,c   Loutzenhiser, Kathy ^c   Loutzenhiser, Rodger D ^c   Walsh, Michael P ^b  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

^b UNIVERSITY OF CALGARY   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

Integrin linked kinase; Myosin phosphorylation; Renal microcirculation; Smooth muscle; Zipperinteracting protein kinase

Indexed keywords

DAPK3 PROTEIN, MOUSE; DEATH ASSOCIATED PROTEIN KINASE; ENDOTHELIN 1; INTEGRIN LINKED KINASE; INTEGRIN-LINKED KINASE; MYOSIN II; MYOSIN LIGHT CHAIN KINASE; MYOSIN LIGHT CHAIN PHOSPHATASE; PROTEIN SERINE THREONINE KINASE;

ACUTE KIDNEY FAILURE; ANIMAL; BRAIN VASOSPASM; CATALYSIS; CHEMISTRY; CORONARY ARTERY SPASM; DRUG EFFECT; GENETICS; HUMAN; HYPERTENSION; KIDNEY CIRCULATION; MICROCIRCULATION; MOLECULARLY TARGETED THERAPY; PHOSPHORYLATION; PHYSIOLOGY; RAT; REVIEW; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION;

ACUTE KIDNEY INJURY; ANIMALS; CATALYSIS; CORONARY VASOSPASM; DEATH-ASSOCIATED PROTEIN KINASES; ENDOTHELIN-1; HUMANS; HYPERTENSION; MICROCIRCULATION; MOLECULAR TARGETED THERAPY; MUSCLE, SMOOTH, VASCULAR; MYOSIN TYPE II; MYOSIN-LIGHT-CHAIN KINASE; MYOSIN-LIGHT-CHAIN PHOSPHATASE; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; RATS; RENAL CIRCULATION; VASOCONSTRICTION; VASOSPASM, INTRACRANIAL;

EID: 84899992604     PISSN: 09168737     EISSN: 18848796     Source Type: Journal    
DOI: 10.1540/jsmr.50.18     Document Type: Article

References (52)

1. 2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases and myosin phosphatase. Physiol Rev. 2003; 83(4): 1325-58.
2. 2+. J Biol Chem. 2002; 277(3): 2186-92.
3. Allen BG, Walsh MP. The biochemical basis of the regulation of smooth-muscle contraction. Trends Biochem Sci. 1994; 19(9): 362-8.
4. Kamm KE, Stull JT. Dedicated myosin light chain kinases with diverse cellular functions. J Biol Chem. 2001; 276(7): 4527-30.
5. Walsh MP. Calcium-dependent mechanisms of regulation of smooth muscle contraction. Biochem Cell Biol. 1991; 69(12): 771-800.
6. 2+ pumps in smooth muscle cells. J Muscle Res Cell Motil. 1993; 14(2): 141-57.
7. Hartshorne DJ, Ito M, Erdödi F. Role of protein phosphatase type 1 in contractile functions: Myosin phosphatase. J Biol Chem. 2004; 279(36): 37211-4.
8. Eto M. Regulation of cellular protein phosphatase-1 (PP1) by phosphorylation of the CPI-17 family, Ckinase-activated PP1 inhibitors. J Biol Chem. 2009; 284(51): 35273-7.
9. Koyama M, Ito M, Feng J, Seko T, Shiraki K, Takase K, Hartshorne DJ, Nakano T. Phosphorylation of CPI-17, an inhibitory phosphoprotein of smooth muscle myosin phosphatase, by Rho-kinase. FEBS Lett. 2000; 475(3): 197-200.
10. Murányi A, Derkach D, Erdödi F, Kiss A, Ito M, Hartshorne DJ. Phosphorylation of Thr695 and Thr850 on the myosin phosphatase target subunit: inhibitory effects and occurrence in A7r5 cells. FEBS Lett. 2005; 579(29): 6611-5.
11. 2+ sensitization as a component of electromechanical and pharmacomechanical coupling in rat ureteric smooth muscle. Cell Calcium. 2011; 50(4): 393-405.
12. Ikebe M, Hartshorne DJ. Phosphorylation of smooth muscle myosin at two distinct sites by myosin light chain kinase. J Biol Chem. 1985; 260(18): 10027-31.
13. Sutherland C, Walsh MP. Myosin regulatory light chain diphosphorylation slows relaxation of arterial smooth muscle. J Biol Chem. 2012; 287(29): 24064-76.
14. 2+-independent phosphorylation of myosin in rat caudal artery and chicken gizzard myofilaments. J Physiol. 1999; 516(3): 805-24.
15. 2+-independent smooth muscle contraction. a novel function for integrin-linked kinase. J Biol Chem. 2001; 276(19): 16365-73.
16. 2+-free smooth muscle contraction via myosin light chain phosphorylation. J Biol Chem. 2001; 276(31): 29567-74.
17. Moffat LD, Brown SB, Grassie ME, Ulke-Lemée A, Williamson LM, Walsh MP, MacDonald JA. Chemical genetics of zipper-interacting protein kinase reveal myosin light chain as a bona fide substrate in permeabilized arterial smooth muscle. J Biol Chem. 2011; 286(42): 36978-91.
18. Miller-Hance WC, Miller JR, Wells JN, Stull JT, Kamm KE. Biochemical events associated with activation of smooth muscle contraction. J Biol Chem. 1988; 263(28): 13979-82.
19. Colburn JC, Michnoff CH, Hsu LC, Slaughter CA, Kamm KE, Stull JT. Sites phosphorylated in myosin light chain in contracting smooth muscle. J Biol Chem. 1988; 263(35): 19166-73.
20. Seto M, Sasaki Y, Sasaki Y. Stimulus-specific patterns of myosin light chain phosphorylation in smooth muscle of rabbit thoracic aorta. Pflügers Arch. 1990; 415(4): 484-9.
21. Seto M, Sasaki Y, Sasaki Y, Hidaka H. Effect of HA1077, protein kinase inhibitor, on myosin phosphorylation and tension in smooth muscle. Eur J Pharmacol. 1991; 195(2): 267-72.
22. Takeya K, Wang X, Kathol I, Loutzenhiser R, Walsh MP. Endothelin-1 induces sustained constriction of the rat renal afferent arteriole via diphosphorylation of the myosin regulatory light chains. J Physiol Sci. 2013; 63(Suppl 1): S275.
23. Obara K, Nishizawa S, Koide M, Nozawa K, Mitate A, Ishikawa T, Nakayama K. Interactive role of protein kinase C-d with Rho kinase in the development of cerebral vasospasm in a canine two-hemorrhage model. J Vasc Res. 2005; 42(1): 67-76.
24. Katsumata N, Shimokawa H, Seto M, Kozai T, Yamawaki T, Kuwata K, Egashira K, Ikegaki I, Asano T, Sasaki Y, Takeshita A. Enhanced myosin light chain phosphorylations as a central mechanism for coronary artery spasm in a swine model with interleukin-1β. Circulation. 1997; 96(12): 4357-63.
25. Shimokawa H, Seto M, Katsumata N, Amano M, Kozai T, Yamawaki T, Kuwata K, Kandabashi T, Egashira K, Ikegaki I, Asano T, Kaibuchi K, Takeshita A. Rho kinase-mediated pathway induces enhanced myosin light chain phosphorylations in a swine model of coronary artery spasm. Cardiovasc Res. 1999; 43(4): 1029-39.
26. Harada T, Seto M, Sasaki Y, London S, Luo Z, Mayberg M. The time course of myosin light-chain phosphorylation in blood-induced vasospasm. Neurosurgery. 1995; 36(6): 1178-82.
27. Seto M, Yano K, Sasaki Y, Azuma H. Intimal hyperplasia enhances myosin phosphorylation in rabbit carotid artery. Exp Mol Pathol. 1993; 58(1): 1-13.
28. 2+-independent MLCK activity in hypertensive rats. Cardiovasc Res. 2011; 91(1): 162-70.
29. Tanaka T, Sobue K, Owada MK, Hakura A. Linear relationship between diphosphorylation of 20 kDa light chain of gizzard myosin and the actin-activated myosin ATPase activity. Biochem Biophys Res Commun. 1985; 131(2): 987-93.
30. Ikebe M, Koretz J, Hartshorne DJ. Effects of phosphorylation of light chain residues threonine 18 and serine 19 on the properties and conformation of smooth muscle myosin. J Biol Chem. 1988; 263(13): 6432-7.
31. Bresnick AR, Wolff-Long VL, Baumann O, Pollard TD. Phosphorylation on threonine-18 of the regulatory light chain dissociates the ATPase and motor properties of smooth muscle myosin II. Biochemistry. 1995; 34(39): 12576-83.
32. Umemoto S, Bengur AR, Sellers JR. Effect of multiple phosphorylations of smooth muscle and cytoplasmic myosins on movement in an in vitro motility assay. J Biol Chem. 1989; 264(3): 1431-6.
33. Sherry JMF, Górecka A, Aksoy MO, Dabrowska R, Hartshorne DJ. Roles of calcium and phosphorylation in the regulation of the activity of gizzard myosin. Biochemistry. 1978; 17(21): 4411-8.
34. Gratecos D, Fischer EH. Adenosine 5'-O-(3-thiotriphosphate) in the control of phosphorylase activity. Biochem Biophys Res Commun. 1974; 58(4): 960-7.
35. Cassidy P, Hoar PE, Kerrick WGL. Irreversible thiophosphorylation and activation of tension in functionally skinned rabbit ileum strips by [35S]ATP?S. J Biol Chem. 1979; 254(21): 11148-53.
36. 2+. J Biol Chem. 1982; 257(11): 5987-90.
37. 2+-independent myosin light chain kinase. Evidence in favor of the phosphorylation theory. Fed Proc. 1983; 42(1): 45-50.
38. Feng J, Ito M, Nishikawa M, Okinaka T, Isaka N, Hartshorne DJ, Nakano T. Dephosphorylation of distinct sites on the 20 kDa myosin light chain by smooth muscle myosin phosphatase. FEBS Lett. 1999; 448(1): 101-4.
39. Loutzenhiser R, Griffin K, Williamson G, Bidani A. Renal autoregulation: new perspectives regarding protective and regulatory roles of the underlying mechanisms. Am J Physiol. 2006; 290(5): R1153-67.
40. Edwards RM, Aiyar N. Angiotensin II receptor subtypes in the kidney. J Am Soc Nephrol. 1993; 3(10): 1643-52.
41. Gómez-Garre D, Largo R, Liu XH, Gutierrez S, López-Armada MJ, Palacios I, Egido J. An orally active ETA/ETB receptor antagonist ameliorates proteinuria and glomerular lesions in rats with proliferative nephritis. Kidney Int. 1996; 50(3): 962-72.
42. Orth SR, Esslinger JP, Amann K, Schwarz U, Raschack M, Ritz E. Nephroprotection of an ETA-receptor blocker (LU 135252) in salt-loaded uninephrectomized stroke-prone spontaneously hypertensive rats. Hypertension. 1998; 31(4): 995-1001.
43. Wilhelm SM, Stowe NT, Robinson AV, Schulak JA. The use of the endothelin receptor antagonist, tezosentan, before and after renal ischemia protects renal function. Transplantation. 2001; 71(2): 211-6.
44. Kon V, Yoshioka T, Fogo A, Ichikawa I. Glomerular actions of endothelin in vivo. J Clin Invest. 1989; 83(5): 1762-7.
45. Loutzenhiser R, Epstein M, Hayashi K, Horton C. Direct visualization of effects of endothelin on the renal microvasculature. Am J Physiol. 1990; 258(1 Pt2): F61-8.
46. Claria J, Jimenez W, La Villa G, Asbert M, Castro A, Llibre JL, Arroyo V, Rivera F. Effects of endothelin on renal haemodynamics and segmental sodium handling in conscious rats. Acta Physiol Scand. 1991; 141(3): 305-8.
47. Harris PJ, Zhuo J, Mendelsohn FA, Skinner SL. Haemodynamic and renal tubular effects of low doses of endothelin in anaesthetized rats. J Physiol. 1991; 433(1): 25-39.
48. 2+ entry. Circ Res. 2000; 87(7): 551-7.
49. Kinoshita E, Kinoshita-Kikuta E, Takiyama K, Koike T. Phosphate-binding tag, a new tool to visualize phosphorylated proteins. Mol Cell Proteomics. 2006; 5(4): 749-57.
50. Takeya K, Loutzenhiser K, Shiraishi M, Loutzenhiser R, Walsh MP. A highly sensitive technique to measure myosin regulatory light chain phosphorylation. The first quantification in renal arterioles. Am J Physiol. 2008; 294(6): F1487-92.
51. Söderberg O, Gullberg M, Jarvius M, Ridderstråle K, Leuchowius KJ, Jarvius J, Wester K, Hydbring P, Bahram F, Larsson LG, Landegren U. Direct observation of individual endogenous protein complexes in situ by proximity ligation. Nat Methods. 2006; 3(12): 995-1000.
52. Shiraishi M, Wang X, Walsh MP, Kargacin G, Loutzenhiser K, Louzenhiser R. Myosin heavy chain expression in renal afferent and efferent arterioles: relationship to contractile kinetics and function. FASEB J. 2003; 17(15): 2284-6.